Specialized healthcare shipping

by Inside Logistics Online Staff

UPS Healthcare has expanded its Premier product line. The UPS Premier portfolio provides three-levels of service.

UPS Premier monitors packages at all times, creating visibility and prioritization for each shipment. In addition, sensor technology enables real-time recovery of shipments if they encounter network delays, temperature deviations, or other issues.

UPS Premier Silver and Gold are now available in major markets around the world. UPS Premier Platinum will be available in the fall. It adds the ability to monitor temperature, light and humidity while tracking shipments in and out of the UPS network.

“The expansion and enhancement of UPS Premier supports the complex needs of our laboratory, medical and pharmaceutical customers around the world,” said EVP and president international, healthcare and supply chain solutions Kate Gutmann.

“Whether efficiently moving healthcare products between countries, maintaining negative 80-degree temperatures or locating life-saving shipments with precision, UPS Premier provides industry-leading visibility, control, reliability and recovery.”

This specialized service connects major global trade lanes and is now expanding geographically. These new offerings provide customers even more benefits, including efficient customs brokerage, environmental monitoring, and visibility to meet the challenges of global healthcare logistics leaders.

“Visibility and traceability are essential to prioritizing the life-saving medications our customers ship and their customers need,” said UPS Healthcare president Wes Wheeler.

“The difference between life and death for patients often hinges on the ability to quickly ship and precisely track, monitor and locate medications.”

Innovations in biologics, specialty pharmaceuticals, and medications genetically personalized for each patient’s needs are driving significant demand for precision logistics to support more patient-critical, time and temperature-sensitive products. The global market for biologic therapeutic drugs is set to increase from US$285.5 billion in 2020 to $421.8 billion by 2025.